News

03.10.2017

"You should always have something crazy cooking on the back burner"

When Jennifer Doudna gave her keynote at Basel Life in September, the auditorium in the Congress Center was packed. Susan Gasser, Professor of Molecular Biology at the University of Basel introduced Doudna as groundbreaking and extremely innovative. The Professor of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley was on top of Gassers wish list for the Basel Life. The leading figure of what is known as the CRISPR revolution among scientists sat down with BaselArea.swiss during her stay in Basel to talk about her lab, flexible career paths and what makes a great researcher.

mehr >
23.10.2017

Roivant enters into partnership with AstraZeneca

Vivek Ramaswamy, Founder and Chief Executive Officer of Roivant Sciences

Basel – The pharmaceutical company Roivant Sciences will develop a drug for AstraZeneca, marking the first time the two companies will work together.

mehr >
23.10.2017

Basilea to receive 5 million Swiss francs

Basilea to receive 5 million Swiss francs

Basel – The Basel-based biopharmaceutical company Basilea is to receive a milestone payment from Astellas Pharma triggered by strong sales of its anti-fungal medication Cresemba in the U.S.

mehr >
29.09.2017

Spirochem opens new state-­of-­the-­art Services and R&D facilities in Basel

Spirochem opens new state-­of-­the-­art Services and R&D facilities in Basel

Basel – The fine chemicals company SpiroChem has relocated to state-of-the-art facilities in the Rosental area of Basel, offering the company an ideal location to significantly expand its operations. SpiroChem has also strengthened its board of directors.

mehr >
19.10.2017

New medicines are driving Roche’s growth

New medicines are driving Roche’s growth

The Basel-based pharmaceutical company Roche increased group sales by 5 per cent in the first nine months of the year. The recently launched medicines Tecentriq, Ocrevus und Alecensa contributed strongly to this growth.

mehr >
18.10.2017

BC Platforms advances multiple sclerosis research

BC Platforms advances multiple sclerosis research

The data management company BC Platforms has announced collaborations with multiple partners to better understand the genetic basis of multiple sclerosis. BC Platforms also intends to build a research platform in Great Britain.

mehr >
18.09.2017

13 startup projects qualify for the first phase of BaseLaunch

13 startup projects qualify for the first phase of BaseLaunch

The BaseLaunch Healthcare Accelerator program from BaselArea.swiss started on September 14. Over 100 applications were received from more than 30 countries, and the selection committee has selected 13 projects to go on to Phase I. Now, the project teams will work with industry experts to further develop their business case over the next three months.

mehr >
17.10.2017

The European Antibody Congress opens its doors

The European Antibody Congress opens its doors

Partnered with Basel Area Swiss and the city of Basel, and now in its 13th year, the European Antibody Congress is bringing together 600 delegates, 200 speakers and 70 exhibitors from big pharma, biotechs, clinicians, researchers and innovative start-ups. The Congress takes place during three consecutive days from 31st October to 2nd November 2017 at the Congress Centre in Basel.

mehr >
17.10.2017

Roche invests in novel antibiotics

Roche invests in novel antibiotics

The Basel-based pharmaceutical company Roche is collaborating with the U.S. biotechnology firm Warp Drive Bio, which developed a proprietary technology platform to discover and develop novel classes of antibiotics.

mehr >
05.09.2017

"In Switzerland, we often sell promising technologies too early"

Ulf Claesson is a "serial entrepreneur". During the past 25 years, he has set up companies that have gone on to become firmly established in the market. In 2012, he joined Clinerion as CEO and shareholder. Since then, the company has positioned itself in the medical data field and recently entered into a partnership with British company Cisiv. Clinerion's software helps recruit patients for clinical trials run by major pharmaceutical companies – in real time. But the competition never sleeps. A growing number of competitors is now appearing, especially in the USA where there is no shortage of risk capital. In this interview for the Innovation Report, Claesson explains how the Basel-based healthtech company plans to maintain its leadership position.

mehr >
16.10.2017

U.S. turns to Swiss-style vocational training

U.S. turns to Swiss-style vocational training

The Swiss vocational education and training system is generating major interest in the U.S. A new report, which has now been presented in Washington, aims to give American companies an overview of how this system operates – and the opportunities it affords.

mehr >
13.10.2017

Novartis pursues digitalization through cooperation

Novartis pursues digitalization through cooperation

Novartis does not intend to sell its stake in its local competitor Roche anytime soon, said chairman of the board Jörg Reinhardt. The company, which aims to achieve digitalization through cooperation, remains committed to Basel.

mehr >
04.07.2017

"I want to turn innovative research into new drugs"

Cellestia CEO Michael Bauer.

Each year some 250,000 patients develop a type of cancer because of faulty communication between cells. This malfunction occurs in what is known as the NOTCH signal path. There are currently no effective treatments – but this is set to change. Cellestia Biotech AG is developing an innovative drug against this type of cancer by using a novel active ingredient that selectively attacks the malfunctioning cell communication. The drug could be used to treat leukaemia, lymphomas and solid tumours such as breast cancer.

mehr >
12.10.2017

BaselArea.swiss opens Representative Office in Shanghai

BaselArea.swiss opens Representative Office in Shanghai

To further strengthen its foothold in China, BaselArea.swiss opened a branch office at the newly established Fenglin Biomedical Center in Shanghai. The office, led by Chief Representative China Mr. GAO Ronghui, will help BaselArea.swiss to promote the Basel region as a prime Life Sciences location and to support Chinese companies interested in expanding their business to Europe.

mehr >
12.10.2017

Polyphor develops inhaled antibiotics

Polyphor develops inhaled antibiotics

The pharmaceutical company Polyphor is launching an inhaled formulation of its innovative antibiotic Murepavadi. It is also supporting a large-scale research project involving numerous European institutions.

mehr >
13.06.2017

Roivant is creating a buzz in Basel

Roivant is creating a buzz in Basel

Roivant Sciences, a fast-growing life sciences company from the US, recently opened its global headquarters in Basel. In celebration of their newly established location, Roivant, together with BaselArea.swiss, invited stakeholders from the life sciences sector to “Halle 7, Gundeldingerfeld” in Basel on June 8th 2017 for a panel discussion on the future of healthcare.

mehr >
11.10.2017

Clariant extends shelf life of nutraceuticals

Clariant extends shelf life of nutraceuticals

The speciality chemicals company Clariant has developed a protective packaging solution that can inhibit the exposure of medically active foodstuffs to damaging oxygen, light and moisture.

mehr >
10.10.2017

The cloud is key for digitalisation

The cloud is key for digitalisation

The Cloud Computing Competence Centre at the FHNW University of Applied Sciences and Arts Northwestern Switzerland has explored the role of the cloud in digitalisation. In a survey, 80% of IT managers stated that they considered the cloud to be essential in this process.

mehr >
08.06.2017

BaselArea.swiss got off to a successful start

BaselArea.swiss got off to a successful start

In its first annual report, the newly formed BaselArea.swiss can look back on a successful 2016. The joint initiative for innovation and economic promotion by the cantons of Basel-Stadt, Basel-Landschaft and Jura succeeded in growing in all areas. It provided assistance to 36 companies moving to the region, which corresponds to a 50% increase over the previous year. In the area of innovation promotion, over 4,000 participants attended 80 events, expanding the regional network from 8,000 to 13,000 innovators and experts. The services provided by BaselArea.swiss were also actively used to promote start-up projects, contributing to 43 companies being founded.

mehr >
09.10.2017

Junge Wissenschaftler bringen ihre Themen in die öffentliche Diskussion

Junge Wissenschaftler bringen ihre Themen in die öffentliche Diskussion

Am 24. Oktober organisiert reatch Basel gemeinsam mit dem Think Tank foraus (forum Aussenpolitik) einen Event mit dem Titel «Genetik im Alltag: Top oder Flop?» CRISPR, Gentests aus dem Internet oder Präimplantationsdiagnostik sind neue Anwendungen der Genetik, mit denen grosse Chancen und Risiken einhergehen. Expertinnen und Experten aus Medizin, Ethik und Wissenschaft diskutieren am runden Tisch mit den Teilnehmenden über die Berührungspunkte genetischer Tests in unserem Alltag.

mehr >
05.10.2017

Terria Mobile joins KPMG

Terria Mobile joins KPMG

The consulting firm KPMG has acquired the Basel-based software developer Terria Mobile. With the acquisition, KPMG is substantially enhancing its range of digital services.

mehr >
08.06.2017

A molecular assembly line to cure the body

A molecular assembly line to cure the body

Imagine that certain forms of blindness could be cured. Or imagine that the body itself could produce a cure for some of its own diseases. These may be just some of the results of the National Centre of Competence in Research Molecular Systems Engineering (NCCR MSE). Its long-term goals are to create molecular systems and factories for the production of high added-value chemicals and develop cellular systems for new applications in medical diagnostics, therapy and treatment. Director Thomas Ward is aiming high: He wants to make Basel the leading hub for the next European flagship project. At stake: one billion euro.

mehr >
03.10.2017

The changing healthcare system in China

The changing healthcare system in China

On September 15th 2017, the first Swiss-Chinese Life Sciences Forum took place at Roche in Basel. The event focused on the two key topics of “Challenges, Responses and Opportunities in the Chinese Health Sector” and “Digital health in China”.

mehr >
03.10.2017

Roivant Sciences recognized with Tell Award for its investment in Basel, Switzerland

Roivant Sciences recognized with Tell Award for its investment in Basel, Switzerland

The global healthcare company Roivant Sciences is a recipient of the 2017 Tell Award in recognition of its significant investment in Basel, Switzerland. The annual Tell Awards – named after the Swiss folk hero Wilhelm Tell - recognizes North American companies that have made substantial and innovative investments in Switzerland.

mehr >
15.05.2017

Investing in strengths – Swiss leadership in life sciences

Investing in strengths – Swiss leadership in life sciences

How can Switzerland and the Basel region maintain their international leadership role in life sciences? As part of the Biotech and Digitization Day, Federal Councillor Johann Schneider-Ammann visited the Basel region to discuss current trends and challenges with a high-ranking delegation from politics, business, research and start-ups.

mehr >
03.10.2017

Myovant therapy effective against uterine fibroids

Myovant therapy effective against uterine fibroids

The Basel-based pharmaceutical company Myovant Sciences has published positive study results for its therapy relugolix, which has now been shown to be effective and safe for the treatment of uterine fibroids.

mehr >
03.10.2017

University of Basel increases support of Innovation

University of Basel increases support of Innovation

The University of Basel is aiming to increasingly support start-ups, knowledge transfer of technology into society and the economy and is seeking more active collaborations with the private industry. With these goals in mind, the University of Basel President’s Board has recently taken several measures.

mehr >
09.05.2017

The healthcare system must take responsibility

The healthcare system must take responsibility

Kristian Schneider wants to improve the quality of health care and better manage the rising healthcare costs by means of a network that includes doctors, hospitals, insurance companies and the state. Its aim is to provide exactly those services needed for the health of patients. For the canton of Jura, which like all other cantons suffers from the fragmentation of service providers, this could be a unique opportunity to build an integrative care system – and thus become a pioneer, says the director of Hôpital du Jura.

mehr >
03.10.2017

The changing healthcare system in China

The changing healthcare system in China

On September 15th 2017, the first Swiss-Chinese Life Sciences Forum took place at Roche in Basel. The event focused on the two key topics of “Challenges, Responses and Opportunities in the Chinese Health Sector” and “Digital health in China”.

mehr >
03.10.2017

Basel Region - a fertile ground for Precision Medicine

Basel Region - a fertile ground for Precision Medicine

What does it take to make precision medicine happen – and why provides Basel the perfect cluster for the development? That is where DayOne comes into play: The innovation hub for precision medicine is a bottom up initiative to break down the silo mentality of healthcare innovation. The group promotes collaboration through events and collaborative projects amongst stakeholders in the region. One important cornerstone is the DayOne Conference that takes place on Wednesday, November 15th at Markthalle Basel, healthcare innovators, practioners, patients, scientists, entrepreneurs, industry experts, researchers and ICT specialists come together to discuss and explore opportunities in creating the future of Health.

mehr >
21.04.2017

Basel-Landschaft welcomes new companies

Basel-Landschaft welcomes new companies

The canton of Basel-Landschaft welcomed a host of new companies over the past few weeks. BaselArea.swiss played in a big role in attracting the companies to establish themselves in Basel.

mehr >
03.10.2017

Un atout opérationnel pour le soutien de l’innovation dans le Jura

Le 8 septembre dernier, M. Jean-Frédéric Gerber, directeur de la Chambre de commerce et d’Industrie du Jura basée à Delémont, a accueilli une vingtaine de ses membres lors d’un traditionnel déjeuner-contact avec des industriels et patrons de PME jurassiennes. M. Christof Klöpper, directeur de BaselArea.swiss et M. Daniel Rüegg, directeur de Creapole SA, également présents en tant qu’orateurs invités, étaient ravis de saluer ce public et de partager un moment convivial autour d’un repas pris en commun à l’issue de la manifestation.

mehr >
02.10.2017

Evolva plans capital increase

The ingredients manufacturer Evolva is planning a capital increase in the amount of 80 million Swiss francs. Evolva aims to break even in four to six years by focusing on three key products.

mehr >
12.04.2017

“I see a very innovation-friendly climate in Basel”

“I see a very innovation-friendly climate in Basel”

It all began with research resources that were a quarter of a century old. Simon Ittig and his colleagues at the Biozentrum of the University of Basel turned these into a research project – and eventually a start-up. T3 Pharmaceuticals develops new therapies to treat solid tumours.

mehr >
28.09.2017

Roche supports U.S. health authority with digital project

Roche supports U.S. health authority with digital project

The U.S. health authority FDA is to pilot a certification program for digital health solutions. The Basel-based pharma giant Roche is among the companies selected to participate in the pilot project. It will give the FDA an insight into its processes.

mehr >
27.09.2017

Narasimhan wants to revolutionize clinical trials

Narasimhan wants to revolutionize clinical trials

Novartis CEO-designate Vasant Narasimhan wants to leverage digital technology to make cost savings in patient recruitment. The aim is to reduce costs in this field by up to a quarter.

mehr >
05.04.2017

Companies continue to find Switzerland appealing

View over the Rhine river

Bern – More foreign companies relocated to Switzerland last year than in any previous year. Economic development agencies attracted innovative companies with high value creation.

mehr >
26.09.2017

New method could speed up blood tests

New method could speed up blood tests

Scientists at Roche and ETH Zurich have developed a new method for analysing liquids. In the future, physicians could perform complex blood or urine tests in their own practice instead of sending them to specialist laboratories.

mehr >
25.09.2017

Roche receives three important drug approvals

Roche receives three important drug approvals

The European Commission granted authorizations to three Roche therapies. They are for the treatment of giant cell arteritis, advanced follicular lymphoma, and for both metastatic lung and metastatic bladder cancer.

mehr >
20.03.2017

Swiss are among the happiest people in the world

Swiss are among the happiest people in the world

Switzerland is one of the four happiest countries in the world, according to the latest World Happiness Report. The study looks at GDP per capita, trust in government and business, and other social factors relating to well-being.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)